|
|
Emergency Department Visits for Antiviral Adverse Events During the 2009 H1N1 Influenza Pandemic (Vol.126 no.3)
Certified in Public Health Continuing Education (CPHCE) Credits
Article: Emergency Department Visits for Antiviral Adverse Events During the 2009 H1N1 Influenza Pandemic
Synopsis: The 2009 pandemic influenza A (H1N1) outbreak was associated with an increased use of antiviral agents and highlighted the role of population-based monitoring for related adverse drug events (ADEs). An ongoing, nationally representative emergency department-based surveillance system was used to identify and characterize ADEs during the pandemic. Active surveillance for ADEs successfully provided timely, population based data during the pandemic. Increases in antiviral ADEs paralleled increases in prescribing. Type and severity of ADEs were similar across all seasons.
How to earn these credits:
Step 1: Read the article listed above
Step 2: Answer Quiz Questions
Step 3: Add to Cart and proceed to Checkout (during checkout you will be asked to create an account where you will enter your demographic information (name, address, etc.) or login to your existing account)
Note:You will have an opportunity to review/edit quiz answers before checking out.
Passing Rate:You must answers 80% of the questions correctly to earn credits - once your passing score has been verified CPHCE credits will be issued in the form of a certificate that will be emailed to you.
Fee is non-refundable. Please allow 48hrs for processing.
|
Quiz Questions
* denotes required field
Please be sure to enter your NBPHE Number correctly. It will appear on your completion certificate that you will need to turn into NBPHE. If don’t have your NBPHE Number, please visit www.nbphe.org*
1. Which of the following is NOT true about the H1N1 influenza outbreak in 2009, as reported in the article?*
2. Which of the following is NOT true of the ED visits used as cases for this study?*
3. Which of the following were among the most common adverse events association with neuraminidase inhibitors, as reported in the text of the article?*
4. Which of the following was the least common adverse event manifestation type reported to DAWN in 2006-2008?*
5. Which of the following was NOT listed as a limitation of this study?*
|
|
|